A Call for Evidence-based Decision Making When Selecting Outcome Measurement Instruments for Summary of Findings Tables in Systematic Reviews: Results from an OMERACT Working Group

Dorcas E Beaton^{1

2}, Caroline B Terwee^{3

4}, Jasvinder A Singh^{3

4}, Gillian A Hawker^{3

4}, Donald L Patrick^{3

4}, Laurie B Burke^{3

4}, Karine Toupin-April^{3

4}, Peter S Tugwell^{3

4}

Affiliations

¹ From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada. beatond@smh.ca.
² D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health. beatond@smh.ca.
³ From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.
⁴ D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health.

PMID: 26373567
DOI: 10.3899/jrheum.141446

A Call for Evidence-based Decision Making When Selecting Outcome Measurement Instruments for Summary of Findings Tables in Systematic Reviews: Results from an OMERACT Working Group

Dorcas E Beaton et al. J Rheumatol. 2015 Oct.

. 2015 Oct;42(10):1954-1961.

doi: 10.3899/jrheum.141446. Epub 2015 Sep 15.

Authors

Dorcas E Beaton^{1

2}, Caroline B Terwee^{3

4}, Jasvinder A Singh^{3

4}, Gillian A Hawker^{3

4}, Donald L Patrick^{3

4}, Laurie B Burke^{3

4}, Karine Toupin-April^{3

4}, Peter S Tugwell^{3

4}

Affiliations

¹ From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada. beatond@smh.ca.
² D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health. beatond@smh.ca.
³ From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto, Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute; Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.
⁴ D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St. Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD, Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH, Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle Quality of Life Group\Center for Disability Policy and Research, University of Washington; L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs, Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April, BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc, University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, Department of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population Health.

PMID: 26373567
DOI: 10.3899/jrheum.141446

Abstract

Objective: Systematic reviews often struggle with how to combine information when more than 1 instrument is used across studies being synthesized. Different techniques have been suggested based on frequency of use in the literature, or on consensus. We explore an approach blending 2 initiatives: OMERACT (Outcome Measurement in Rheumatology) and COSMIN (Consensus On Selection of Measurement Instruments), and investigate the effects of an evidence-based measurement approach on selection of outcomes.

Methods: Readings were circulated to attendees registered for a preconference workshop on pain measurement. Three instruments were considered and exercises conducted to engage people in the content and measurement performance of these tools. Consensus was sought that an evidence-based approach could be created for selection of instruments for summary of findings (SoF) tables.

Results: The blending of COSMIN and OMERACT approaches led to an evidence-based approach that depended both on a clear definition of target concept and a review of measurement performance of the instrument. Participants emphasized that conceptual clarity and practical considerations should come before measurement property results.

Conclusion: Evidence-based approaches can be adopted for selection of instruments for SoF tables. A research agenda was formulated.

Keywords: EVIDENCE BASED; HEALTH STATUS INDICATORS; OUTCOME MEASUREMENT; REPRODUCIBILITY OF RESULTS; SYSTEMATIC REVIEWS.

PubMed Disclaimer

Cited by

Cross-cultural survey development: The Colon Cancer Screening Behaviors Survey for South Asian populations.
Crawford J, Beaton D, Ahmad F, Bierman AS. Crawford J, et al. BMC Res Notes. 2017 Dec 28;10(1):770. doi: 10.1186/s13104-017-3098-3. BMC Res Notes. 2017. PMID: 29282127 Free PMC article.
Responsiveness and Minimally Important Differences for 4 Patient-Reported Outcomes Measurement Information System Short Forms: Physical Function, Pain Interference, Depression, and Anxiety in Knee Osteoarthritis.
Lee AC, Driban JB, Price LL, Harvey WF, Rodday AM, Wang C. Lee AC, et al. J Pain. 2017 Sep;18(9):1096-1110. doi: 10.1016/j.jpain.2017.05.001. Epub 2017 May 10. J Pain. 2017. PMID: 28501708 Free PMC article. Clinical Trial.
Patient reported outcome measures in neurogenic bladder.
Clark R, Welk B. Clark R, et al. Transl Androl Urol. 2016 Feb;5(1):22-30. doi: 10.3978/j.issn.2223-4683.2015.12.05. Transl Androl Urol. 2016. PMID: 26904409 Free PMC article. Review.
Evaluation of the psychometric properties of patient-reported and clinician-reported outcome measures of chemotherapy-induced peripheral neuropathy: a COSMIN systematic review protocol.
Bérubé-Mercier P, Tapp D, Cimon MÈ, Li T, Park SB, Bouhêlier É, McGarragle K, Robichaud LA, Gewandter JS, Bouchard M, Gauthier LR. Bérubé-Mercier P, et al. BMJ Open. 2022 Apr 6;12(4):e057950. doi: 10.1136/bmjopen-2021-057950. BMJ Open. 2022. PMID: 35387828 Free PMC article.
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
Orbai AM, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W, Campbell W, FitzGerald O, Gladman DD, Goel N, Gossec L, Hoejgaard P, Leung YY, Lindsay C, Strand V, van der Heijde DM, Shea B, Christensen R, Coates L, Eder L, McHugh N, Kalyoncu U, Steinkoenig I, Ogdie A. Orbai AM, et al. J Rheumatol. 2017 Oct;44(10):1522-1528. doi: 10.3899/jrheum.160904. Epub 2017 Feb 1. J Rheumatol. 2017. PMID: 28148697 Free PMC article.

See all "Cited by" articles

LinkOut - more resources

Full Text Sources
- HighWire
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A Call for Evidence-based Decision Making When Selecting Outcome Measurement Instruments for Summary of Findings Tables in Systematic Reviews: Results from an OMERACT Working Group

Affiliations

A Call for Evidence-based Decision Making When Selecting Outcome Measurement Instruments for Summary of Findings Tables in Systematic Reviews: Results from an OMERACT Working Group

Authors

Affiliations

Abstract

Similar articles

Cited by

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous